Management of the extrahepatic symptoms of chronic hepatitis C: Feasibility of a randomized controlled trial of exercise

American Journal of Physical Medicine and Rehabilitation

Volumn 92, Issue 6, 2013, Pages 504-512

  McKenna, Olivia ^a   Cunningham, Caitriona ^b   Gissane, Conor ^c   Blake, Catherine ^b  

^a Midwestern Regional Hospital   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c ST MARY'S UNIVERSITY   (United Kingdom)

Author keywords

Exercise Training; Hepatitis C; Physical Function; Quality of Life; RCT

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EXERCISE; EXERCISE TOLERANCE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HAND STRENGTH; HEPATITIS C; HUMAN; IATROGENIC DISEASE; IRELAND; KINESIOTHERAPY; MALE; METHODOLOGY; MIDDLE AGED; MUSCLE STRENGTH; PAIN; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PHYSIOLOGY; PHYSIOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; TIME; TREATMENT OUTCOME;

DEPRESSION; EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HAND STRENGTH; HEPATITIS C, CHRONIC; HUMANS; IATROGENIC DISEASE; IRELAND; MALE; MIDDLE AGED; MUSCLE STRENGTH; PAIN; PATIENT SATISFACTION; PHYSICAL THERAPY MODALITIES; QUALITY OF LIFE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84878867361     PISSN: 08949115     EISSN: 15377385     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31828cd500     Document Type: Article

References (32)

1. Perillo R, Rothstein K, Rubin R, et al: Comparison of quality of life, work productivity and medical resource utilisation of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribaviran as initial treatment in patients with chronic hepatitis C. J Viral Hepat 2004;11:157-65
2. Bonkovsky H, Woolley J: The Consensus Interferon Study Group: Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999;29:264-70
3. McKenna O, Cunningham C, Blake C: Sociodemographic and clinical features of Irish iatrogenic hepatitis C patients: A cross-sectional survey. BMC Public Health 2009;9:323
4. Barkhuizen A, Rosen H, Wolf S, et al: Musculoskeletal pain and fatigue are associated with chronic hepatitis C. Am J Gastroenterol 1999;94:1355-60
5. Lauer G, Walker B: Hepatitis C virus infection. N Engl J Med 2001;345:41-52
6. Stockton K: Exercise training in patients with chronic liver disease. Physiother Theory Pract 2001;17:29-38
7. Epstein S, Ciubotaru R, Zilberberg M, et al: Analysis of impaired exercise capacity in patients with cirrhosis. Dig Dis Sci 1998;43:1701-7
8. McKenna O, Blake C: Management of hepatitis C: The potential benefits of exercise. Phys Ther Rev 2007;12: 271-6
9. Konishi I, Hiasa Y, Tokumoto Y, et al: Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus. Hepatol Res 2011;41:928-35
10. McGee H, Hickey A, Brady M, et al: Review of Health Services for Persons Who Contracted Hepatitis C Through the Administration Within the State of Blood and Blood Products. Implementation of Recommendations. Consultative Council on Hepatitis C. Dublin, Department of Health and Children, 2005
11. Thomas S, Reading J, Shephard R: Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can J Sport Sci 1992;17:338-45
12. WorldHealth Organization: International Classification of Functioning, Disability and Health (ICF). Geneva, Switzerland, World Health Organization, 2001
13. Mathiowetz V, Kashman N, Volland G, et al: Grip and pinch strength: Normative data for adults. Arch Phys Med Rehabil 1985;66:69-74
14. Guralnik J, Simonsick E, Ferrucci L, et al: A short physical performance battery assessing lower extremity function: Association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-94
15. Duncan P, Studenski S: Balance and Gait Measures. New York, NY, Springer Publishing Co, 1994
16. Bradley J, Howard J, Wallace E, et al: Validity of a modified shuttle test in adult cystic fibrosis. Thorax 1999;54:437-9
17. Huskisson E: Measurement of pain. Lancet 1974; 2:1127-31
18. Zigmond A, Snaith R: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70
19. Multiple Sclerosis Council for Clinical Practice Guidelines: Fatigue and Mulitple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis. Washington, DC, Paralyzed Veterans of America, 1998, pp. 1-33
20. Ware J, Snow K, Kosinski M, et al: SF-36 Health Survey Manual and Interpretation Guide. Boston, MA, New England Medical Centre, The Health Institute, 1993
21. Borg G: Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982;14:377-81
22. American College of Sports Medicine: ACSM's Guidelines for Exercise Testing and Prescription, ed. 6. Philadelphia, Lippincott Williams & Wilkins, 2000
23. Altman D, Schulz K, Moher D, et al, for the CONSORT Group: The revised CONSORT statement for reporting randomised trials: Explanation and elaboration. Ann Intern Med 2001;134:663-94
24. International Association for the Study of Pain. Available at: www.iasp-pain.org. Accessed November 16, 2012
25. Ritland S, Petlund C, Knudsen T, et al: Improvement of physical capacity after long-term training in patients with chronic active hepatitis. Scand J Gastroenterol 1983;18:1083-7
26. Larose J, Sigal R, Boule N, et al: The effect of exercise training on physical fitness in type 2 diabetes mellitus. Med Sci Sports Exerc 2010;42:1439-47
27. Hickman I, Jonsson J, Prins J, et al: Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin and quality of life. Gut 2004;53:413-9
28. Zucker D: An intervention to prevent symptoms associated with hepatitis C: A pilot study. Appl Nurs Res 2010;23:116-20
29. Vazquez-Vandyck M, Roman S, Vazquez J, et al: Effect of breathwalk on body composition, metabolic and mood state in chronic hepatitis C patients with insulin resistance syndrome. World J Gastroenterol 2007;13:6213-8
30. Spiegel B, Younossi Z, Hays R, et al: Impact of hepatitis C on health related quality of life: Systematic review and quantitative assessment. Hepatology 2005;41:790-800
31. Coughlan B, Sheehan J, Hickey A, et al: Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection. Br J Health Psychol 2002;7:105-16
32. Thornton L, Murphy N, McIver M, et al: National Hepatitis C Database for Infection Acquired Through Blood and Blood Products. Baseline report. Health Protection Surveillance Centre, Dublin, Department of Health and Children, 2007